Pte Ltd. Biolexis serves as Executive at Outlook Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Pte Ltd. Biolexis has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 21, 2022 involved transacting 27,982,529 shares valued at $0.
Pte Ltd. Biolexis currently holds 22,982,529 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pte Ltd. Biolexis has been a net neutral trader of OTLK stock. They have purchased $0 and sold $0 worth of shares.
Pte Ltd. Biolexis's most recent insider trade was on Apr 21, 2022, when they sold 27,982,529 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 3, 2018 | OTLK | $4.0M | Award | 4,288,624 | $0.93 | Discretionary |
| Nov 7, 2018 | ONS | $8.0M | Award | 8,577,248 | $0.93 | Discretionary |